Mor Research Applications

Mor Research Applications is the technology-transfer and commercialization arm of Clalit Health Services, Israel’s largest health maintenance organization, with a structural advantage that few investors anywhere can match: access to insights and data generated across Clalit’s massive patient and provider network. The fund’s mandate is to transform those insights into globally scalable health solutions, with a focus on digital health, medical devices, and diagnostics.

The thesis is rooted in the Clalit network. Mor identifies clinical needs, research insights, and operational pain points within Clalit’s hospitals and clinics, supports the formation of companies around them, and provides early capital and structural support to translate those insights into products. Digital health, medical devices, and diagnostics are the most active categories, with AI in healthcare appearing where the data infrastructure makes new approaches viable. The fund’s positioning as the commercialization arm of an HMO is unusual and gives portfolio companies access to clinical and operational validation environments that other investors cannot offer.

Check sizes sit below 250 thousand dollars, consistent with the pre-seed positioning and the technology-transfer model. Stage focus is firmly at the start: pre-seed and seed, with follow-on capital expected from Israeli healthtech-specialist funds and international Series A investors as the companies mature. Geography is Israel-anchored, with the Clalit network providing initial validation and the broader Israeli healthtech ecosystem providing commercial pathways.

The team is small and embedded in Clalit’s research, clinical, and operational structures, with deep institutional knowledge of the HMO’s data assets and clinical workflows. Diligence is built around the Clalit-fit value proposition.

Approach Mor when you are a Clalit clinician, researcher, or graduate with a research-derived invention or clinical insight, or when you are an outside founder building a digital health, device, or diagnostics product that would genuinely benefit from Clalit’s data and operational depth. Pure outside founders without a Clalit anchor will be a worse fit. The most direct path in is through Clalit clinicians, the HMO’s research programs, or the Mor office directly. Time the conversation when you have a research insight or early product idea, ideally with a clinical co-founder or sponsor inside the system. Founders should plan for a structured commercialization process and a long-term partnership with the HMO.